Richard A. Leach
Director/Miembro de la Junta en Meenta, Inc. .
Origen de la red de primer grado Richard A. Leach.
| Entidad | Tipo de entidad | Industria | |
|---|---|---|---|
deCODE genetics, Inc.
 deCODE genetics, Inc. Pharmaceuticals: GenericHealth Technology deCODE genetics, Inc. is a bio-pharmaceutical company. It developing and marketing products to improve the treatment, diagnosis and prevention of common diseases. deCODE applies its capabilities in chemistry and structural biology to the development of drugs in major therapeutic areas, and applies its discoveries in human genetics to bring to market DNA-based reference laboratory tests and consumer genome analysis services to assess individual risk of common diseases. The company was founded by Kari Stefansson and Jeffrey Gulcher in August 1996 and is headquartered in Reykjavík, Iceland.
26
| Extinct | Pharmaceuticals: Generic | 26 |
Fjord Holding LLC
 Fjord Holding LLC Medical/Nursing ServicesHealth Services NextCODE Health LLC provides clinical diagnosis services. It is a sequence-based clinical diagnostics company delivering a powerful solution to genome interpretation and big data challenges. The company was founded in 2013 by Jeffrey Gulcher and Hannes Thor Smarason and is headquartered in Cambridge, MA.
7
| Subsidiary | Medical/Nursing Services | 7 |
Meenta, Inc.
 Meenta, Inc. Internet Software/ServicesTechnology Services Meenta, Inc. engages in the development of digital platform for clinical testing and science industry. Its product enables scientists to find instruments and for hosts to offer instruments for bookings. The company was founded by Gabor Bethlendy and Stephan Smith in 2016 and is headquartered in Boston, MA.
4
| Private Company | Internet Software/Services | 4 |
Gráfico Empresas conectadas de segundo grado
Relaciones con varias empresas
Empresas conectadas a Richard A. Leach a través de su red personal
| Empresa | Sector | Personas relacionadas | Puesto principal |
|---|---|---|---|
| University of Iceland | College/University | Undergraduate Degree Undergraduate Degree Doctorate Degree Graduate Degree Corporate Officer/Principal Undergraduate Degree Doctorate Degree Undergraduate Degree | |
deCODE Genetics ehf
 deCODE Genetics ehf Miscellaneous Commercial ServicesCommercial Services deCODE genetics engages in a biopharmaceuticals company. It provides research services with focus on human genes. The company was founded by K?ri Stef?nsson in August 1996 and is headquartered in Reykjavik, Iceland. | Miscellaneous Commercial Services | Corporate Officer/Principal Chief Executive Officer Chief Administrative Officer Director/Board Member Corporate Officer/Principal Chief Tech/Sci/R&D Officer Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
| The University of Chicago | College/University | Doctorate Degree Doctorate Degree Corporate Officer/Principal | |
Harvard University
 Harvard University Other Consumer ServicesConsumer Services Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA. | College/University | Corporate Officer/Principal Undergraduate Degree Doctorate Degree | |
| ÍSLANDSBANKI HF. | Regional Banks | Director/Board Member General Counsel | |
| PFIZER, INC. | Pharmaceuticals: Major | Director/Board Member Corporate Officer/Principal | |
National Academy of Medicine (United States)
 National Academy of Medicine (United States) Miscellaneous Commercial ServicesCommercial Services The National Academy of Medicine (United States) is based in Washington and is focused on improving the health and well-being of individuals through various initiatives. These initiatives include the clinician well-being collaborative, which aims to accelerate the implementation of a national plan for health workforce well-being, and the development of a code of conduct for the use of artificial intelligence in health care. The organization also provides resources to support meaningful community engagement in health and health care programs and policies. Recently, the National Academy of Medicine announced the appointment of Mandy Cohen, a member of the organization, as the director of the Centers for Disease Control and Prevention. Additionally, the organization has released a publication celebrating 50 years of progress in biomedical science, health, and health care. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal | |
Arsenal Medical, Inc.
 Arsenal Medical, Inc. Miscellaneous Commercial ServicesCommercial Services Arsenal Medical Inc. develops therapeutic products based on BioActive Composites platform. Its biomaterials-based systems provide targeted local and systemic therapies to treat chronic diseases and conditions. The firm product offers tailored dosing of drugs, mechanical and biochemical compatibility with tissues and complete bioabsorption. The company was founded by George M. Whitesides, Carmichael S. Roberts Jr. and Robert S. Langer Jr. in 2005 and is headquartered in Watertown, MA. | Miscellaneous Commercial Services | Director/Board Member Chief Executive Officer | |
| GENSIGHT BIOLOGICS S.A. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Beth Israel Hospital
 Beth Israel Hospital Medical/Nursing ServicesHealth Services Beth Israel Hospital provides healthcare services. The private company is based in Boston, MA. | Medical/Nursing Services | Corporate Officer/Principal Corporate Officer/Principal | |
| ILLUMINA, INC. | Biotechnology | Director/Board Member Corporate Officer/Principal | |
| GSK PLC | Pharmaceuticals: Major | General Counsel Chief Tech/Sci/R&D Officer | |
Genuity Science, Inc.
 Genuity Science, Inc. Packaged SoftwareTechnology Services Genuity Science develops cloud based programs to improve health and support wellness. Its products include products include SeqPlus, Clinical Sequence Analyzer, RareCODE CSA, CancerCODE, GeneCODE, RareCODE, FamilyCODE and HealthCODE. The company was founded by Smarason Hannes and Gulcher Jeffrey in 2013 and is headquartered in Shanghai, China. | Packaged Software | Chairman Chief Executive Officer | |
| NICOX SA | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| University of Uppsala | College/University | Undergraduate Degree Graduate Degree | |
| HUA MEDICINE (SHANGHAI) LTD. | Pharmaceuticals: Major | Chairman Founder | |
| NANEXA AB | Medical Specialties | Chairman Director/Board Member | |
National Venture Capital Association
 National Venture Capital Association Miscellaneous Commercial ServicesCommercial Services National Venture Capital Association provides business association services. It facilitates networking opportunities and provides research data to its members. The company is headquartered in Washington, DC. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
| Astra Research Centre AB | Chairman Chief Tech/Sci/R&D Officer | ||
| Harvard Medical School | College/University | Corporate Officer/Principal Corporate Officer/Principal | |
Genomics Medicine Ireland Ltd
 Genomics Medicine Ireland Ltd Information Technology ServicesTechnology Services Genomics Medicine Ireland Ltd. operates as a biotechnology company. It develops new treatments and diagnostics across a spectrum of chronic health conditions. The company was founded by Daniel Crowley, Sean Ennis, Paul Thurk, and Maurice N. Treacy in 2015 and is headquartered in Dublin, Ireland. | Information Technology Services | Director/Board Member Director/Board Member | |
| The University of Texas at Austin | College/University | Undergraduate Degree Undergraduate Degree | |
| NEUMORA THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Wuxi NextCode Genomics USA, Inc.
 Wuxi NextCode Genomics USA, Inc. Data Processing ServicesTechnology Services Wuxi NextCode Genomics USA, Inc. provides genomic data. It's solutions include custom patient cohorts, sequencing, analysis, AI services, sequence miner, and clinical sequence analyzer. The company was founded by Jeffrey Gulcher and Hannes Smarason and is headquartered in Cambridge, MA. | Data Processing Services | Founder Chief Executive Officer | |
DGI Resolution, Inc.
 DGI Resolution, Inc. Miscellaneous Commercial ServicesCommercial Services DGI Resolution, Inc. operates as a biopharmaceutical company. It discovers human genetics to develop drugs for common diseases. The company was founded by Kari Stefansson and Jeffrey Gulcher and is headquartered in New York, NY. | Miscellaneous Commercial Services | Founder Founder | |
| Massachusetts Institute of Technology | College/University | Doctorate Degree Masters Business Admin | |
TransMedics, Inc.
 TransMedics, Inc. Medical SpecialtiesHealth Technology TransMedics, Inc. manufactures and develops medical devices. It offers a portable warm blood perfusion system designed to maintain organs in a functioning state outside the human body during transport from organ donor to recipient. The firm’s products are used in heart, lung, liver, and kidney transplants. The company was founded by Waleed H. Hassanein in August 1998 and is headquartered in Andover, MA. | Medical Specialties | Director/Board Member Director/Board Member | |
| Kellogg School of Management | College/University | Masters Business Admin | |
| NOVO NORDISK A/S | Pharmaceuticals: Major | Chairman | |
S*BIO Pte Ltd.
 S*BIO Pte Ltd. Pharmaceuticals: MajorHealth Technology S*BIO is a privately-held biotech company focused on the research and clinical development of novel targeted small molecule drugs for the treatment of cancer with leading programs around histone deacetylases (HDAC) and kinases. S*BIO's lead candidate, SB939, entered the clinic in 2007. SB1518, S*BIO's potent and orally-active JAK2 inhibitor, entered the clinic in 2008 and has received orphan drug designation from the U.S. FDA. S*BIO has entered into a development collaboration, and option & license agreement with Onyx Pharmaceuticals, Inc. to develop and commercialize SB1518 and its other novel JAK2 inhibitor, SB1578. S*BIO's SB1317, a novel multikinase inhibitor, is in pre-clinical development and under a worldwide exclusive license with Tragara Pharmaceuticals, Inc. for its development and commercialization. In line with its vision to be a leading fully-integrated oncology-focused biotech company in Asia Pacific, S*BIO has established a state-of-the-art R&D infrastructure, complemented by a strong clinical development team. S*BIO has strong links with a network of medical oncologists in Asia Pacific and its investors include EDB Investments' biomedical sciences subsidiary Bio*One Capital, Aravis Ventures, Novartis Bioventures and other international funds. In 2009, S*BIO received the BioSpectrum Editor's Choice, Emerging BioScience Company of Singapore Award. | Pharmaceuticals: Major | Director/Board Member | |
| COATS GROUP PLC | Textiles | Director/Board Member | |
| VICTREX PLC | Chemicals: Major Diversified | Chief Executive Officer | |
| Valsmenn hf | Director/Board Member | ||
Newton-Wellesley Hospital Corp.
 Newton-Wellesley Hospital Corp. Hospital/Nursing ManagementHealth Services Newton-Wellesley Hospital Corp. provides health care services. Its services include medical, surgical and diagnostic services. The company was founded in 1881 and is headquartered in Newton, MA. | Hospital/Nursing Management | Chairman | |
Chroma Therapeutics Ltd.
 Chroma Therapeutics Ltd. BiotechnologyHealth Technology Chroma Therapeutics Ltd. engages in the discovery and development of therapies for the treatment of cancer and inflammation. It focuses on the discovery and development of novel small molecule drugs based upon chromatin biology and novel cell accumulation approaches. The firm uses chromatin biology, drug accumulation approaches to discover and develop cancer, inflammation treatments and small molecule drugs. The company was founded by David Allis, Alan Hornsby Davidson, Alan Hastings Drummond, Anthony Kouzarides and Paul Workman in September 2001 and is headquartered in Abingdon, the United Kingdom. | Biotechnology | Director/Board Member | |
| ENZON PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member | |
Jazz Pharmaceuticals UK Ltd.
 Jazz Pharmaceuticals UK Ltd. Pharmaceuticals: MajorHealth Technology Jazz Pharmaceuticals UK Ltd. is pharmaceutical company focused on in-licensing, developing and marketing late-stage oncology, oncology supportive care and critical care products. The company was founded in 2006 and is headquartered in Oxford, United Kingdom. | Pharmaceuticals: Major | Director/Board Member | |
| Yale University | College/University | Undergraduate Degree | |
| EYEPOINT PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Chairman |
Estadísticas
Internacional
| Estados Unidos | 25 |
| Reino Unido | 7 |
| Suecia | 6 |
| Islandia | 5 |
| Francia | 4 |
Sectorial
| Health Technology | 25 |
| Consumer Services | 9 |
| Commercial Services | 7 |
| Technology Services | 4 |
| Finance | 3 |
Operativa
| Director/Board Member | 239 |
| Corporate Officer/Principal | 87 |
| Chairman | 50 |
| Independent Dir/Board Member | 46 |
| Founder | 31 |
Las relaciones más conectadas
| Insiders | |
|---|---|
| Robert Nelsen | 80 |
| Terry McGuire | 51 |
| Göran Albert Ando | 44 |
| Birgit Stattin Norinder | 29 |
| Earl Collier | 24 |
| Ge Li | 23 |
| Thomas Caskey | 21 |
| Helga Zharov | 15 |
| Dan Hartman | 14 |
| Tómas Sigurðsson | 14 |
| Jakob Sigurðsson | 14 |
| Peter Goodfellow | 13 |
| Daniel C. Siu | 12 |
| Lance Thibault | 11 |
| James R. Beery | 11 |
- Bolsa de valores
- Insiders
- Richard A. Leach
- Conexiones Empresas
